/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S.
WIRE SERVICES/
WINNIPEG, Jan. 22, 2018 /CNW/ - Delta 9 Cannabis
Inc. (TSXV:NINE) ("Delta 9" or the "Company") today
announced that it has granted, effective today, an aggregate of
671,700 stock options (each an "Option") to certain directors,
officers, employees and consultants of the Company in accordance
with the Company's current stock option plan. Each Option is
exercisable into one common share (a "Share") of the Company at a
price of $2.77 per Share for a period
of five years from the date of grant, being today. The Options will
vest over twelve months, with one third vesting immediately, one
third vesting on the date that is six months from the date hereof
and the remaining one third vesting on the date that is twelve
months from the date hereof.
The issuance of the Options is subject to the approval of the
TSX Venture Exchange. If the issuance of the Options is approved by
the TSX Venture Exchange, the Options will be subject to a minimum
hold period of 4 months and one day in accordance with applicable
securities laws.
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned
subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of
medical marijuana pursuant to the Access to Cannabis for Medical
Purposes Regulations and operates an approximately 80,000 square
foot production facility in Winnipeg,
Manitoba, Canada. Delta 9's shares trade on the TSX Venture
Exchange under the symbol "NINE".
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Delta 9 Cannabis Inc.